Parameter | DM (n = 16) | Non-DM (n = 12) | P |
Age, mean ± SD | 60.7 ± 8.1 | 65.02 ± 10.1 | 0.3 |
Gender | All men | 0.57 | |
Smoker, (n), (%) | 10 (35%) | 8 (20.5%) | 0.23 |
CAD, (n), (%) | 7 | 4 | 0.7 |
HT, (n), (%) | 11 | 8 | 0.9 |
COPD, (n), (%) | 2 | 4 | 0.3 |
CAD history | 8 | 5 | 0.7 |
Diabeticfoot | 7 | 0 | <0.01 |
Aspirine | 10 | 8 | 0.4 |
DMAH | 5 | 3 | 0.9 |
Clopidogrel | 8 | 6 | 0.9 |
Femoropopliteal bypass | 7 | 8 | 0.2 |
Aortobifemoral bypass (ABF) | 4 | 1 | 0.3 |
İleofemoral bypass | 2 | - | - |
Pseudoaneurisym | 2 | - | - |
Redo-femoropopliteal bypass | 1 | - | - |
Distallimb bypass | - | 1 | - |
Redo ABF | - | 1 | - |
Embolectomy | - | 1 | - |
Preop-ABI | 0.6 (0.52 - 0.8) | 0.5 (0.44 - 0.82) | 0.7 |
Postop-ABI | 0.6 (0.53 - 0.81) | 0.6 (0.5 - 0.84) | 0.8 |
X clamptimes. median, IQR | 40 (25 - 45) | 42.5 (25 - 52.5) | 0.5 |
Postoperativepulses | Inallpalpable |